AAAAAA

   
Results: 1-10 |
Results: 10

Authors: PIEDRA PA GRACE S JEWELL A SPINELLI S HOGERMAN DA MALINOSKI F HIATT PW
Citation: Pa. Piedra et al., SEQUENTIAL ANNUAL ADMINISTRATION OF PURIFIED FUSION PROTEIN VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN WITH CYSTIC-FIBROSIS, The Pediatric infectious disease journal, 17(3), 1998, pp. 217-224

Authors: HONG F RUIZ R PRICE H GRIFFITHS A MALINOSKI F WOLOSKI M
Citation: F. Hong et al., SAFETY PROFILE OF WINRHO ANTI-D, Seminars in hematology, 35(1), 1998, pp. 9-13

Authors: DAUM RS HOGERMAN D RENNELS MB BEWLEY K MALINOSKI F ROTHSTEIN E REISINGER K BLOCK S KEYSERLING H STEINHOFF M
Citation: Rs. Daum et al., INFANT IMMUNIZATION WITH PNEUMOCOCCAL CRM197 VACCINES - EFFECT OF SACCHARIDE SIZE ON IMMUNOGENICITY AND INTERACTIONS WITH SIMULTANEOUSLY ADMINISTERED VACCINES, The Journal of infectious diseases, 176(2), 1997, pp. 445-455

Authors: PIEDRA PA HIATT PW GRACE S JEWELL A HOGERMAN D MALINOSKI F
Citation: Pa. Piedra et al., SAFETY OF SEQUENTIAL ANNUAL ADMINISTRATION OF PEP-2 VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN CHILDREN WITH CYSTIC-FIBROSIS (CF), Clinical infectious diseases, 23(4), 1996, pp. 68-68

Authors: KING JC VINK PE FARLEY JJ PARKS M SMILIE M MADORE D LICHENSTEIN R MALINOSKI F
Citation: Jc. King et al., COMPARISON OF THE SAFETY AND IMMUNOGENICITY OF A PNEUMOCOCCAL CONJUGATE WITH A LICENSED POLYSACCHARIDE VACCINE IN HUMAN DEFICIENCY VIRUS AND NONHUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN, The Pediatric infectious disease journal, 15(3), 1996, pp. 192-196

Authors: AHMAN H KAYHTY H TAMMINEN P VUORELA A MALINOSKI F ESKOLA J
Citation: H. Ahman et al., PENTAVALENT PNEUMOCOCCAL OLIGOSACCHARIDE CONJUGATE VACCINE PNCCRM IS WELL-TOLERATED AND ABLE TO INDUCE AN ANTIBODY-RESPONSE IN INFANTS, The Pediatric infectious disease journal, 15(2), 1996, pp. 134-139

Authors: PIEDRA PA GRACE S JEWELL A SPINELLI S BUNTING D HOGERMAN DA MALINOSKI F HIATT PW
Citation: Pa. Piedra et al., PURIFIED FUSION PROTEIN VACCINE PROTECTS AGAINST LOWER RESPIRATORY-TRACT ILLNESS DURING RESPIRATORY SYNCYTIAL VIRUS SEASON IN CHILDREN WITHCYSTIC-FIBROSIS, The Pediatric infectious disease journal, 15(1), 1996, pp. 23-31

Authors: KING J VINK P FARLEY J PARKS M SMILIE M HOGERMAN D MALINOSKI F
Citation: J. King et al., SAFETY AND IMMUNOGENICITY OF 3 DOSES OF A 5-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) IN HIV AND NON-HIV-INFECTED CHILDREN LESS-THAN-2 YRS OF AGE, Pediatric research, 39(4), 1996, pp. 1037-1037

Authors: KING JC VINK P SMILIE M PARKS M MADORE D MALINOSKI F
Citation: Jc. King et al., SAFETY AND IMMUNOGENICITY OF A 5-VALENT CONJUGATE PNEUMOCOCCAL VACCINE (CPV) IN HIV(-HIV-INFECTED(-) CHILDREN() AND NON), Pediatric research, 37(4), 1995, pp. 180-180

Authors: DAUM R STEINHOFF M RENNELS M ROTHSTEIN E RESINGER K KEYSERLING H BLACK S MALINOSKI F
Citation: R. Daum et al., EVALUATION OF STREPTOCOCCUS-PNEUMONIAE OLIGOSACCHARIDE AND POLYSACCHARIDE CRM197 CONJUGATE VACCINES IN HEALTHY UNITED-STATES INFANTS, Pediatric research, 35(4), 1994, pp. 10000177-10000177
Risultati: 1-10 |